RxDoctor Payments Data

Stacy Kuiper

Nurse Practitioner · West Des Moines, IANPI 1336764182

Payments from drug & device makers

$1,416in general payments, 2019–2025

Across 97 payments — averaging $14.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$258
  • Novo Nordisk$255
  • Amgen$171
  • Boehringer Ingelheim$114
  • Takeda Pharmaceuticals U.S.A., Inc.$81
  • Merck$58
  • plus $479 from 15 others

What the payments were for

  • Food & beverage$1,416100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,416 in reported general payments places this provider in the 85th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide144$162,903
XareltoRivaroxaban143$119,767
JardianceEmpagliflozin101$93,763
TrulicityDulaglutide33$39,644
EliquisApixaban38$39,261
Tresiba Flextouch U-200Insulin Degludec27$37,839
MounjaroTirzepatide25$26,609
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog41$23,952
FarxigaDapagliflozin Propanediol28$22,099
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$19,826
Lantus SolostarInsulin Glargine,hum.Rec.Anlog122$19,561
InvokanaCanagliflozin15$13,743
JanuviaSitagliptin Phosphate11$10,892
Breo ElliptaFluticasone/Vilanterol23$10,804
EntrestoSacubitril/Valsartan15$8,383

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$255$162,903144 claims
Boehringer IngelheimJardiance, Stiolto Respimat$114$98,876112 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$49$69,14473 claims
AstraZenecaFarxiga, Brilinta$28$26,75839 claims
MerckJanuvia$58$10,89211 claims
NovartisEntresto$15$8,38315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,346 nurse practitioner providers in Iowa.

Other nurse practitioner in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →